IBD Research Resource Center

Clinical ID	c2075
Identifier	ACTRN12624000678594
Trial Title	Treatment of functional gut symptoms in patients with quiescent inflammatory bowel disease and irritable bowel syndrome - A single-blinded parallel trial assessing efficacy of app-delivered gut-directed hypnotherapy versus psychoeducation
Trial URL	Visit Original Page

Study Results	No results available
Conditions	Inflammatory Bowel Disease;Irritable Bowel Syndrome ; Inflammatory Bowel Disease Irritable Bowel Syndrome ;Oral and Gastrointestinal - Inflammatory bowel disease;Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Interventions	Participants will be randomised to receive app-delivered gut-directed hypnotherapy (GDH) or psychoeduation (control) for 6 weeks. Adherence to both interventions will be available through app analytics. GDH: Participants receiving GDH treatment will download an app specifically designed for this study onto their personal mobile device. The mobile delivered app will guide participants through daily GDH recordings for six weeks, each recording taking approximately 15-20 minutes to complete. The GDH involves an induction whereby the participant is invited to relax before suggestions for the control and normalisation of gastrointestinal function are made to the subconscious mind. An example of a metaphor would be to ask the participant to imagine swallowing down medicine and imagining that this medicine provides healing and protection to the gastrointestinal tract thus reducing gastrointestinal symptoms. Hypnotherapy recordings have been prepared by a qualified hypnotherapist (SLP) with experience in the utilisation of GDH.

Sex Requirement	ALL
Age Requirement	ADULT, OLDER_ADULT

Study Type	Interventional
Phase	Not Available